Susquehanna International Group’s Encompass Health EHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.16M | Buy |
+32,700
| New | +$3.35M | ﹤0.01% | 5172 |
|
|
2025
Q4 | – | Sell |
-27,200
| Closed | -$3.45M | – | 12632 |
|
|
2025
Q3 | $3.45M | Buy |
+27,200
| New | +$3.24M | ﹤0.01% | 4711 |
|
|
2024
Q4 | – | Sell |
-9,400
| Closed | -$908K | – | 12428 |
|
|
2024
Q3 | $908K | Sell |
9,400
-9,400
| -50% | -$845K | ﹤0.01% | 7004 |
|
|
2024
Q2 | $1.61M | Sell |
18,800
-215,100
| -92% | -$18.1M | ﹤0.01% | 5514 |
|
|
2024
Q1 | $19.3M | Buy |
+233,900
| New | +$17.1M | ﹤0.01% | 1815 |
|
|
2023
Q4 | – | Sell |
-20,800
| Closed | -$1.4M | – | 12555 |
|
|
2023
Q3 | $1.4M | Sell |
20,800
-7,500
| -27% | -$516K | ﹤0.01% | 5890 |
|
|
2023
Q2 | $1.92M | Buy |
28,300
+16,400
| +138% | +$1.03M | ﹤0.01% | 5235 |
|
|
2023
Q1 | $644K | Buy |
+11,900
| New | +$693K | ﹤0.01% | 7951 |
|
|
2022
Q4 | – | Sell |
-9,100
| Closed | -$412K | – | 12705 |
|
|
2022
Q3 | $412K | Buy |
+9,100
| New | +$455K | ﹤0.01% | 8985 |
|
|
2022
Q2 | – | Sell |
-10,182
| Closed | -$576K | – | 13125 |
|
|
2022
Q1 | $576K | Sell |
10,182
-21,872
| -68% | -$1.14M | ﹤0.01% | 8606 |
|
|
2021
Q4 | $1.66M | Sell |
32,054
-10,056
| -24% | -$519K | ﹤0.01% | 5956 |
|
|
2021
Q3 | $2.51M | Buy |
42,110
+14,707
| +54% | +$925K | ﹤0.01% | 5333 |
|
|
2021
Q2 | $1.7M | Sell |
27,403
-5,279
| -16% | -$352K | ﹤0.01% | 6303 |
|
|
2021
Q1 | $2.13M | Buy |
32,682
+18,729
| +134% | +$1.22M | ﹤0.01% | 5781 |
|
|
2020
Q4 | $918K | Sell |
13,953
-31,676
| -69% | -$1.86M | ﹤0.01% | 6913 |
|
|
2020
Q3 | $2.36M | Sell |
45,629
-13,324
| -23% | -$684K | ﹤0.01% | 4306 |
|
|
2020
Q2 | $2.9M | Buy |
58,953
+17,723
| +43% | +$956K | ﹤0.01% | 3855 |
|
|
2020
Q1 | $2.1M | Sell |
41,230
-10,433
| -20% | -$602K | ﹤0.01% | 3887 |
|
|
2019
Q4 | $2.85M | Sell |
51,663
-21,494
| -29% | -$1.17M | ﹤0.01% | 3782 |
|
|
2019
Q3 | $3.68M | Sell |
73,157
-27,654
| -27% | -$1.39M | ﹤0.01% | 3169 |
|
|
2019
Q2 | $5.08M | Buy |
100,811
+42,989
| +74% | +$2.09M | ﹤0.01% | 2690 |
|
|
2019
Q1 | $2.69M | Buy |
57,822
+880
| +2% | +$44.6K | ﹤0.01% | 3313 |
|
|
2018
Q4 | $2.79M | Sell |
56,942
-54,680
| -49% | -$3.11M | ﹤0.01% | 3041 |
|
|
2018
Q3 | $6.92M | Buy |
111,622
+102,697
| +1,151% | +$6.24M | ﹤0.01% | 2302 |
|
|
2018
Q2 | $481K | Buy |
+8,925
| New | +$446K | ﹤0.01% | 6866 |
|
|
2017
Q2 | – | Sell |
-6,159
| Closed | -$210K | – | 9310 |
|
|
2017
Q1 | $210K | Sell |
6,159
-45,378
| -88% | -$1.49M | ﹤0.01% | 7923 |
|
|
2016
Q4 | $1.69M | Sell |
51,537
-48,395
| -48% | -$1.57M | ﹤0.01% | 4431 |
|
|
2016
Q3 | $3.23M | Sell |
99,932
-22,374
| -18% | -$725K | ﹤0.01% | 2794 |
|
|
2016
Q2 | $3.78M | Buy |
122,306
+1,885
| +2% | +$59K | ﹤0.01% | 2598 |
|
|
2016
Q1 | $3.6M | Buy |
+120,421
| New | +$3.32M | ﹤0.01% | 2765 |
|
|
2014
Q4 | – | Sell |
-7,291
| Closed | -$214K | – | 9703 |
|
|
2014
Q3 | $214K | Sell |
7,291
-19,357
| -73% | -$590K | ﹤0.01% | 8568 |
|
|
2014
Q2 | $760K | Sell |
26,648
-13,450
| -34% | -$375K | ﹤0.01% | 6634 |
|
|
2014
Q1 | $1.15M | Buy |
40,098
+17,346
| +76% | +$452K | ﹤0.01% | 5271 |
|
|
2013
Q4 | $603K | Buy |
+22,752
| New | +$633K | ﹤0.01% | 6396 |
|
Other funds holding EHC
VPM
VCM
Susquehanna International Group's EHC Position: Q1 2026 in Review
Susquehanna International Group increased its Encompass Health (EHC) stake by 100% in Q1 2026, buying an estimated $1.96M and bringing the position to 38,172 shares worth $3.69M. The position accounts for ﹤0.01% of the portfolio, ranked #4827.
Susquehanna International Group first reported a position in EHC in Q2 2013 and has held it in 43 quarters since. The position peaked at $16.8M in Q2 2018. 578 funds tracked by Wall St. Rank hold EHC as of Q1 2026.
- Susquehanna International Group held 38,172 shares of Encompass Health worth $3.69M as of Q1 2026.
- Susquehanna International Group bought 19,129 Encompass Health shares in Q1 2026, an estimated $1.96M.
- Encompass Health made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #4827 holding.
- Susquehanna International Group first reported a position in Encompass Health in Q2 2013 and has held it in 43 quarters since.
- Susquehanna International Group's Encompass Health position peaked at $16.8M in Q2 2018.
- 578 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.